Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Trials ; 22(1): 625, 2021 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-34526071

RESUMO

BACKGROUND: The focus of care has shifted from institutional care to home care. Family caregivers provide the majority of home care that allows an opportunity for their care recipients to live at home and avoid costly institutional care. The aim of this study is to describe the nutritional status, oral health, and quality of life of family caregivers over the age of 65 and their care recipients, and to evaluate the impact of individually tailored diet and oral health advice to their nutritional status and oral health. METHODS/DESIGN: Altogether, 250 family caregivers aged 65 or over, and their care recipients are studied in this prospective randomized population-based multidisciplinary 6-month intervention study. Participants are randomly allocated to the intervention groups or the control group. Data collection is performed at three time-points: at baseline and 6 months and after a 6-month follow-up at 12 months. Caregivers' and their care recipients' nutritional and oral health status as a primary outcome, and functional ability, cognitive status, quality of life, depression symptoms, sense of coherence, morbidity, and medication of family caregivers as secondary outcomes will be measured using validated self-administered questionnaires and clinical examinations. DISCUSSION: To our knowledge, this is the first experiment to determine whether caregivers and their care recipients benefit from individual nutritional intervention and oral health intervention in terms of nutrition status, oral health status, and quality of life. TRIAL REGISTRATION: ClinicalTrials.gov NCT04003493 . Registered on June 28, 2019.


Assuntos
Cuidadores , Saúde Bucal , Humanos , Estado Nutricional , Estudos Prospectivos , Qualidade de Vida , Ensaios Clínicos Controlados Aleatórios como Assunto
2.
Liver Transpl ; 20(1): 72-80, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24142471

RESUMO

Immunosuppressive drugs and other medications may predispose patients to oral diseases. Data on oral mucosal health in recipients of liver transplantation (LT) are limited. We, therefore, recruited 84 LT recipients (64 with chronic liver disease and 20 with acute liver failure) for clinical oral examinations in a cross-sectional, case-control study. Their oral health had been clinically examined before transplantation. The prevalence of oral mucosal lesions (OMLs) was assessed in groups with different etiologies of liver disease and in groups with different immunosuppressive medications, and these groups were compared to controls selected from a nationwide survey in Finland (n = 252). Risk factors for OMLs were evaluated with logistic regression. OMLs were more frequent in LT recipients versus controls (43% versus 15%, P < 0.001), and the use of steroids raised the prevalence to 53%. Drug-induced gingival overgrowth was the single most common type of lesion, and its prevalence was significantly higher for patients using cyclosporine A (CSA; 29%) versus patients using tacrolimus (TAC; 5%, P = 0.007); the prevalence was even higher with the simultaneous use of calcium channel blockers and CSA (47%) or TAC (8%, P = 0.002). Lesions with malignant potential such as drug-induced lichenoid reactions, oral lichen planus-like lesions, leukoplakias, and ulcers occurred in 13% of the patients with chronic liver disease and in 6% of the controls. Every third patient with chronic liver disease had reduced salivary flow, and more than half of all patients were positive for Candida; this risk was higher with steroids. In conclusion, the high frequency of OMLs among LT recipients can be explained not only by immunosuppressive drugs but also by other medications. Because dry mouth affects oral health and OMLs may have the potential for malignant transformation, annual oral examinations are indicated.


Assuntos
Doença Hepática Terminal/terapia , Doenças da Gengiva/induzido quimicamente , Imunossupressores/uso terapêutico , Falência Hepática Aguda/terapia , Transplante de Fígado , Mucosa Bucal/patologia , Adulto , Idoso , Bloqueadores dos Canais de Cálcio/efeitos adversos , Estudos de Casos e Controles , Estudos Transversais , Ciclosporina/efeitos adversos , Doença Hepática Terminal/complicações , Feminino , Humanos , Imunossupressores/efeitos adversos , Leucoplasia/induzido quimicamente , Líquen Plano/induzido quimicamente , Falência Hepática Aguda/complicações , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Úlceras Orais/induzido quimicamente , Prevalência , Fatores de Risco , Tacrolimo/efeitos adversos
3.
Amyloid ; 20(1): 39-44, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-23356404

RESUMO

Hereditary gelsolin amyloidosis (AGel amyloidosis) is a rare, dominantly inherited systemic disease with worldwide distribution, caused by c.654G > A or c.654G > T gelsolin gene mutation. The disease mainly manifests with late-onset dystrophy of the cornea, laxity of the skin and dysfunction of the cranial nerves whereas the oral manifestations have remained less-studied. To examine if AGel amyloidosis also affects salivary gland function, we studied 27 patients. In a questionnaire, 89% of them reported oral dryness, and 74% oral and ocular dryness. Unstimulated (UWS) and stimulated whole salivary flow (SWS) rates were measured, and salivary proteins were analyzed in the patients and controls. Hyposalivation according to UWS was detected in 67% of the patients, while decreased SWS occurred in 63% of the patients and 19% of the controls (p = 0.001). The secretion rates of salivary total protein and IgA were significantly lower in patients than controls. Histopathological analyses of labial salivary gland biopsies showed deposition of gelsolin amyloid, atrophy and inflammation. This study showed that AGel amyloidosis belongs to the differential diagnostic choices to be kept in mind in the patients presenting with xerostomia, low secretion rates of salivary total protein and IgA and/or deposition of amyloid in the minor salivary glands. AGel amyloidosis patients should be advised for efficient dental care.


Assuntos
Amiloide/análise , Amiloidose Familiar/patologia , Gelsolina/genética , Imunoglobulina A/análise , Glândulas Salivares Menores/metabolismo , Proteínas e Peptídeos Salivares/análise , Xerostomia/patologia , Idoso , Amiloide/metabolismo , Amiloidose Familiar/complicações , Amiloidose Familiar/diagnóstico , Amiloidose Familiar/metabolismo , Estudos de Casos e Controles , Feminino , Gelsolina/metabolismo , Humanos , Imunoglobulina A/metabolismo , Masculino , Pessoa de Meia-Idade , Mutação , Glândulas Salivares Menores/química , Proteínas e Peptídeos Salivares/metabolismo , Taxa Secretória , Inquéritos e Questionários , Xerostomia/complicações , Xerostomia/diagnóstico , Xerostomia/metabolismo
4.
Liver Transpl ; 19(2): 155-63, 2013 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-23172817

RESUMO

Recipients of liver transplantation (LT) receive lifelong immunosuppression, which causes side effects. We investigated self-reported oral symptoms and associated risk factors with the following hypothesis: symptoms and signs would differ between LT recipients of different etiology groups and also between LT recipients and a control population. Eighty-four LT recipients (64 with chronic liver disease and 20 with acute liver disease) were recruited for clinical oral and salivary examinations (median follow-up = 5.7 years). A structured questionnaire was used to record subjective oral symptoms. Matched controls (n = 252) came from the National Finnish Health 2000 survey. The prevalence of symptoms was compared between the groups, and the risk factors for oral symptoms were analyzed. Xerostomia was prevalent in 48.4% of the chronic LT recipients and in 42.1% of the acute LT recipients. This subjective feeling of dry mouth was only partly linked to objectively measured hyposalivation. The chronic transplant recipients had significantly lower unstimulated salivary flow rates than the acute transplant recipients (0.34 ± 0.31 versus 0.61 ± 0.49 mL/minute, P = 0.005). Among the chronic transplant recipients, hyposalivation with unstimulated salivary flow was associated with fewer teeth (17.7 ± 8.2 versus 21.9 ± 8.4, P = 0.047) and more dentures (33.3% versus 12.2%, P = not significant). The chronic patients reported significantly more dysphagia than their controls (23.4% versus 11.5%, P = 0.02). Increases in the number of medications increased the symptoms in all groups. In conclusion, dysphagia was significantly more prevalent among the chronic LT recipients versus the controls. The number of medications was a risk factor for dry mouth-related symptoms for both the LT recipients and the controls. The chronic transplant recipients presented with lower salivary flow rates than the acute transplant recipients. Hyposalivation correlated with generally worse oral health among the chronic transplant recipients. These differences between the chronic and acute LT recipients may have been due to differences in their medical conditions due to the different etiologies.


Assuntos
Transtornos de Deglutição/induzido quimicamente , Disgeusia/induzido quimicamente , Doença Hepática Terminal/cirurgia , Imunossupressores/efeitos adversos , Falência Hepática Aguda/cirurgia , Transplante de Fígado/imunologia , Doenças da Boca/induzido quimicamente , Autorrelato , Adulto , Idoso , Estudos de Casos e Controles , Distribuição de Qui-Quadrado , Transtornos de Deglutição/epidemiologia , Disgeusia/epidemiologia , Doença Hepática Terminal/epidemiologia , Feminino , Finlândia/epidemiologia , Humanos , Imunossupressores/administração & dosagem , Falência Hepática Aguda/epidemiologia , Transplante de Fígado/efeitos adversos , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Doenças da Boca/epidemiologia , Doenças da Boca/fisiopatologia , Razão de Chances , Saúde Bucal , Prevalência , Medição de Risco , Fatores de Risco , Salivação , Fatores de Tempo , Perda de Dente/induzido quimicamente , Perda de Dente/epidemiologia , Resultado do Tratamento , Xerostomia/induzido quimicamente , Xerostomia/epidemiologia , Adulto Jovem
5.
J Clin Periodontol ; 38(9): 787-94, 2011 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-21770993

RESUMO

AIM: The aim of this cross-sectional study was to investigate whether serum total cholesterol/high-density lipoprotein cholesterol (TC/HDL) ratio and low-density lipoprotein cholesterol/high-density lipoprotein cholesterol (LDL/HDL) ratio are associated with periodontal infection. MATERIALS AND METHODS: This study was based on a subpopulation of the Health 2000 Survey, which included dentate, non-diabetic subjects who had never smoked and who were aged between 30 and 49 years (n=1297). The numbers of teeth with deepened (4 mm deep or deeper) and with deep (6 mm deep or deeper) periodontal pockets were used as outcome variables, as well as the presence of gingival bleeding. RESULTS: We found no consistent associations between TC/HDL or LDL/HDL ratios and the number of teeth with deepened periodontal pockets or the presence of gingival bleeding among normal weight subjects. Nor were there any consistent associations between TC/HDL or LDL/HDL ratios and the number of teeth with deepened periodontal pockets or the presence of gingival bleeding among subjects whose body mass index was 25 or more. CONCLUSIONS: This study does not provide evidence that unfavourable lipid composition can be considered as an important risk for periodontal infection in a general adult population.


Assuntos
Colesterol/sangue , Infecções/sangue , Bolsa Periodontal/sangue , Adulto , HDL-Colesterol/sangue , LDL-Colesterol/sangue , Análise por Conglomerados , Estudos Transversais , Escolaridade , Feminino , Finlândia , Humanos , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Higiene Bucal , Índice Periodontal , Risco
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...